Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-γ activation and function in lipid homeostasis and energy expenditure

Medicine & Life Sciences

• Lipocalin-2 84%
• Peroxisome Proliferator-Activated Receptors 76%
• Energy Metabolism 57%
• Homeostasis 46%
• Rosiglitazone 44%
• Lipids 41%
• Brown Adipose Tissue 14%
• Fatty Acids 9%
• Adipose Tissue 9%
• Insulin Resistance 9%
• Uncoupling Protein 1 8%
• Lipogenesis 7%
• Gene Expression 6%
• Subcutaneous Fat 6%
• High Fat Diet 5%
• Lipid Metabolism 5%
• Adipocytes 5%
• Hydrolysis 5%
• Cold Temperature 5%
• Blood Glucose 4%
• Fats 4%
• Body Weight 4%
• Obesity 4%
• Insulin 3%
• Cytokines 3%
• Liver 2%

Chemical Compounds

• Rosiglitazone 100%
• Lipid 43%
• Insulin Derivative 38%
• Fat 37%
• Energy 29%
• Triglyceride 26%
• Peroxisome Proliferator Activated Receptor Agonist 22%
• Fatty Acid 20%
• Sensitization 13%
• Metabolic 10%
• Pharmacological Metabolism 9%
• Glucose 9%
• Resistance 7%
• Hydrolysis 7%
• Weight 6%
• Oxidation Reaction 5%